Karen M. Marzlin – Cardiac Medications

Karen M. Marzlin – Cardiac Medications

”

Hemodynamics and Shock

• Physiological determinants of myocardial performance
• Vasodilators
  • Vasopressors
  • Inotropes
  • Shock: Dopamine versus Norepinephrine
  • Nuances of decompensated heart failure

Risk Factor Optimization

• Statin therapy in primary and secondary prevention
• Other Antilipid agents: when to use what?
• Outcome trials for lipid lowering agents
  • AIM High
  • Thrive
• Drug choices in hypertension
• Resistant hypertension

Atrial Fibrillation

• Antiarrhythmic pharmacology for rate control
• Antiarrhythmic pharmacology for rhythm control
• Clinical implications of potassium channel blockers
• Special considerations for Dronedarone and Amiodarone
• Anticoagulant medication options
  • Fibrinolytics
  • Anticoagulants
  • Antiplatelets

Therapeutic Advances for Acute Coronary Syndrome

• Prasugrel
• Ticagrelor
• Epleranone post-STEMI
• Non-Steroidals
• ASA and CABG
• Contrast nephropathy

Heart Failure

• Optimal loop diuretic / dose and route of administration
• Nesiritide
• OPTIME Trial
• Serelaxin
• RAAS drugs
• Evidence-based beta blockers
• Drugs not to give for systolic dysfunction

”
Get Karen M. Marzlin – Cardiac Medications at tenco.pro